Alprazolam treatment of postcoronary bypass anxiety and depression

Arthur M. Freeman, Fleece Louie, David G. Folks, Roberta S. Sokol, Kenneth R. Hall, Albert D. Pacifico, David C. McGiffin, James K. Kirklin, George L. Zorn, Robert B. Karp

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)


The effectiveness of alprazolam in treating symptoms of anxiety and depression in 60 patients undergoing coronary bypass surgery was assessed in a double-blind, placebo-controlled study. The results indicate that alprazolam treatment for anxiety following coronary bypass surgery, particularly symptoms occurring in the immediate postoperative period, can significantly affect patient outcome. Specifically, only modest but statistically significant improvement was observed in the alprazolam-treated groups at 1-month followup; however, alprazolam-treated patients were significantly more likely to experience a very rapid anxiolytic effect by postoperative day 8. The implications of this study are discussed with respect to patient management and models for future studies of anxiety in postoperative patient populations.

Original languageEnglish
Pages (from-to)39-41
Number of pages3
JournalJournal of Clinical Psychopharmacology
Issue number1
Publication statusPublished - Feb 1986
Externally publishedYes

Cite this